TCL Archive Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops August 1, 1997
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014